SELLAS Life Sciences Statistics Share Statistics SELLAS Life Sciences has 105.3M
shares outstanding. The number of shares has increased by 55.1%
in one year.
Shares Outstanding 105.3M Shares Change (YoY) 55.1% Shares Change (QoQ) 9.83% Owned by Institutions (%) 16.28% Shares Floating 104.98M Failed to Deliver (FTD) Shares 10,394 FTD / Avg. Volume 0.41%
Short Selling Information The latest short interest is 20.89M, so 16.71% of the outstanding
shares have been sold short.
Short Interest 20.89M Short % of Shares Out 16.71% Short % of Float 16.86% Short Ratio (days to cover) 11.02
Valuation Ratios The PE ratio is -20.61 and the forward
PE ratio is -4.47.
SELLAS Life Sciences's PEG ratio is
0.31.
PE Ratio -20.61 Forward PE -4.47 PS Ratio 0 Forward PS 4.7 PB Ratio 67.25 P/FCF Ratio -17.98 PEG Ratio 0.31
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for SELLAS Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.72,
with a Debt / Equity ratio of 0.11.
Current Ratio 1.72 Quick Ratio 1.72 Debt / Equity 0.11 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.06M Employee Count 15 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 29.37% in the
last 52 weeks. The beta is 2.54, so SELLAS Life Sciences's
price volatility has been higher than the market average.
Beta 2.54 52-Week Price Change 29.37% 50-Day Moving Average 1.74 200-Day Moving Average 1.46 Relative Strength Index (RSI) 42.03 Average Volume (20 Days) 2,522,223
Income Statement
Revenue n/a Gross Profit n/a Operating Income -31.51M Net Income -30.88M EBITDA -30.88M EBIT -30.88M Earnings Per Share (EPS) -0.05
Full Income Statement Balance Sheet The company has 13.99M in cash and 1M in
debt, giving a net cash position of 12.98M.
Cash & Cash Equivalents 13.99M Total Debt 1M Net Cash 12.98M Retained Earnings -248.13M Total Assets 32.3M Working Capital 23.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -35.4M
and capital expenditures 0, giving a free cash flow of -35.4M.
Operating Cash Flow -35.4M Capital Expenditures n/a Free Cash Flow -35.4M FCF Per Share -0.06
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SLS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SLS is $7,
which is 329.4% higher than the current price. The consensus rating is "Strong Buy".
Price Target $7 Price Target Difference 329.4% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 8, 2019. It was a
backward
split with a ratio of 1:50.
Last Split Date Nov 8, 2019 Split Type backward Split Ratio 1:50
Scores Altman Z-Score 4.6 Piotroski F-Score 1
